Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-17 Purchase |
2025-03-17 7:07 pm |
aTYR PHARMA INC | ATYR | Gross Jane A Director |
3,750 | $4 | $15,000 | 9,750 (Direct) |
View |
2025-02-04 Sale |
2025-02-04 6:14 pm |
aTYR PHARMA INC | ATYR | Broadfoot Jill Marie Chief Financial Officer |
1,254 | $3.78 | $4,740 | 35,513 (Direct) |
View |
2025-02-04 Sale |
2025-02-04 6:11 pm |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
899 | $3.78 | $3,398 | 29,242 (Direct) |
View |
2024-07-22 Purchase |
2024-07-24 5:29 pm |
aTYR PHARMA INC | ATYR | SCHIMMEL PAUL Director |
100,000 | $1.8461 | $184,613 | 1,101,056 (Indirect Direct) |
View |
2024-06-05 Purchase |
2024-06-06 08:26 am |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
5,000 | $1.8552 | $9,276 | 22,267 (Direct) |
View |
2024-05-30 Purchase |
2024-06-03 4:21 pm |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
50,000 | $1.75 | $87,500 | 56,000 (Indirect) |
View |
2024-05-31 Purchase |
2024-06-03 08:38 am |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
5,000 | $1.79 | $8,950 | 27,960 (Direct) |
View |
2024-05-31 Purchase |
2024-06-03 08:34 am |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
20,000 | $1.807 | $36,140 | 136,548 (Direct) |
View |
2024-02-06 Sale |
2024-02-06 8:18 pm |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
1,590 | $1.69 | $2,687 | 28,321 (Direct) |
View |
2023-12-11 Purchase |
2023-12-12 6:50 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
15,000 | $1.1764 | $17,646 | 106,173 (Direct) |
View |
2023-11-10 Purchase |
2023-11-13 4:11 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
15,000 | $1.1136 | $16,703 | 91,173 (Direct) |
View |
2023-07-28 Purchase |
2023-08-01 4:07 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
15,000 | $2.0149 | $30,224 | 76,173 (Direct) |
View |
2023-05-10 Purchase |
2023-05-11 09:00 am |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
200,000 | $2.25 | $450,000 | 1,001,056 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-03 Exercise |
2025-02-04 6:18 pm |
N/A N/A |
aTYR PHARMA INC | ATYR | Shukla Sanjay President and CEO |
10,375 | $0 | 157,298 (Direct) |
View |
2025-02-03 Exercise |
2025-02-04 6:14 pm |
N/A N/A |
aTYR PHARMA INC | ATYR | Broadfoot Jill Marie Chief Financial Officer |
3,750 | $0 | 35,513 (Direct) |
View |
2025-02-03 Exercise |
2025-02-04 6:11 pm |
N/A N/A |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
2,687 | $0 | 29,242 (Direct) |
View |
2025-01-08 Option Award |
2025-01-10 4:07 pm |
N/A 2035-01-08 |
aTYR PHARMA INC | ATYR | Shukla Sanjay President and CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
2025-01-08 Option Award |
2025-01-10 4:05 pm |
N/A 2035-01-08 |
aTYR PHARMA INC | ATYR | Broadfoot Jill Marie Chief Financial Officer |
275,000 | $0 | 275,000 (Direct) |
View |
2025-01-08 Option Award |
2025-01-10 4:01 pm |
N/A 2035-01-08 |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
275,000 | $0 | 275,000 (Direct) |
View |
2024-12-10 Option Award |
2024-12-12 4:15 pm |
N/A 2034-12-10 |
aTYR PHARMA INC | ATYR | BENEVICH ERIC Director |
100,000 | $0 | 100,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 7:30 pm |
N/A 2034-05-22 |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 7:27 pm |
N/A 2034-05-22 |
aTYR PHARMA INC | LIFE | Gross Jane A Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 7:19 pm |
N/A 2034-05-22 |
aTYR PHARMA INC | LIFE | Lucas Svetlana Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 7:16 pm |
N/A 2034-05-22 |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 7:11 pm |
N/A 2034-05-22 |
aTYR PHARMA INC | LIFE | Zaknoen Sara Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 7:07 pm |
N/A 2034-05-22 |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-02-05 Exercise |
2024-02-06 8:20 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
10,375 | $0 | 137,298 (Direct) |
View |
2024-02-05 Exercise |
2024-02-06 8:18 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
3,750 | $0 | 28,321 (Direct) |
View |
2024-02-05 Exercise |
2024-02-06 8:15 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
2,688 | $0 | 20,141 (Direct) |
View |
2024-01-05 Option Award |
2024-01-09 7:35 pm |
N/A 2034-01-05 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
600,000 | $0 | 600,000 (Direct) |
View |
2024-01-05 Option Award |
2024-01-09 7:33 pm |
N/A 2034-01-05 |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
150,000 | $0 | 168,661 (Direct) |
View |
2024-01-05 Option Award |
2024-01-09 7:30 pm |
N/A 2034-01-05 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
150,000 | $0 | 162,079 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:33 pm |
N/A 2033-05-17 |
aTYR PHARMA INC | LIFE | Zaknoen Sara Director |
12,000 | $0 | 12,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:32 pm |
N/A 2033-05-17 |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
12,000 | $0 | 12,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:30 pm |
N/A 2033-05-17 |
aTYR PHARMA INC | LIFE | Lucas Svetlana Director |
12,000 | $0 | 12,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:29 pm |
N/A 2033-05-17 |
aTYR PHARMA INC | LIFE | Gross Jane A Director |
12,000 | $0 | 12,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:27 pm |
N/A 2033-05-17 |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
12,000 | $0 | 18,000 (Direct) |
View |
2023-05-17 Gift |
2023-05-19 4:27 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
6,000 | $0 | 18,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:23 pm |
N/A 2033-05-17 |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
12,000 | $0 | 12,000 (Direct) |
View |
2023-04-26 Exercise |
2023-04-28 4:56 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Zaknoen Sara Director |
6,000 | $0 | 6,000 (Direct) |
View |
2023-04-26 Exercise |
2023-04-28 4:54 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
6,000 | $0 | 19,797 (Direct) |
View |
2023-04-26 Exercise |
2023-04-28 4:54 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
6,000 | $0 | 801,056 (Direct) |
View |
2023-04-26 Exercise |
2023-04-28 4:53 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Lucas Svetlana Director |
6,000 | $0 | 6,000 (Direct) |
View |